Hospitals are improving their ability to prevent medication errors by enhancing their use of electronic medication safety systems, data from The Leapfrog Group's fall 2024 safety grade report ...
Azurity Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved Danziten™, the first and only nilotinib with no mealtime restrictions indicated for adult patients ...
The drug distributor will buy a majority stake in gastroenterology practice management group GI Alliance and purchase ...
In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...
Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of ...
The pharmaceutical distributor has launched InspiroGene, a business unit offering logistics and other support for ...
The health-tech industry’s long-term growth is fueled by the growing need for cutting-edge technologies to address critical ...
The companies, McKesson and AmerisourceBergen, will split over $266 million in past and future damages if the verdict ...
It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions ...
We rate McKesson as a 'Strong Buy' with focus on GLP-1 meds, oncology network, and strong Q2 results driving future growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback